Alere Inc. (Formerly Inverness Medical Innovations, Inc.)

United States of America Country flag United States of America
Sector: Medical Supplies
Ticker: ALR
Factsheet Factsheet
INACTIVE

Profitability Analysis of Alere Inc. ( ALR | USA)

The Profitability Score is a relevant measure for the assessment of a stock attractiveness. Alere Inc. shows a Profitability Score of N/A.
The Profitability Score for Alere Inc. is lower than its peer group's. This means that Alere Inc. has a lower profitability than its peer group.

Valuation
EV/EBITDA LastEV/EBITDA(e) 2024EV/EBITDA NTM
International PeersFree trialFree trialFree trial
Medical SuppliesN/A11.1410.93
N/AN/AN/AN/A
United States of AmericaN/A8.948.74
More...
Betanull
Levered betaUnlevered beta
1-YearN/AN/A
2-YearN/AN/A
3-YearN/AN/A
More...
Stock Perf excl. Dividends (in N/A)
ALRN/ARel. Perf.
Year-to-DateN/AN/AN/A
1-WeekN/AN/AN/A
1-MonthN/AN/AN/A
1-YearN/AN/AN/A
3-YearN/AN/AN/A
5-YearN/AN/AN/A
More...
GPRV Analysis
GPRV® analysis is not available due to one of the
following reasons:
  • - Company is not covered by analysts (no estimates)
  • - Company is an insurance company
More...
International Peers - Alere Inc.
Company NameCtryMarket
Cap.
last (mUSD)
Alere Inc.USAN/A
International Peers Median0.90
Hologic Inc.USA17 592
Meridian Bioscience Inc...USAN/A
DiaSorin S.p.A.ITA6 130
Abbott LaboratoriesUSA182 435
Roche Holding AGCHE209 444
Net Sales
No data available for this instrument.
Quotes Chart

1-Year Rebased Stock Chart

  • Alere Inc.
More...

About Stock Profitability Analysis

Aggregated Profitability Score
In GPRV, the Aggregated Profitability Score is the average of the profitability indicators' scores.

EBIT Margin Historical
This is a weighted average of the Historical EBIT Margins.
Calculation: (using up to 5 years of historical data when available)
[EBIT Margin year N*5 + EBIT Margin year (N-1)*4 + EBIT Margin year (N-2)*3 + EBIT Margin year (N-3)*2 + EBIT Margin (N-4)] / 15

EBIT Margin NTM
This is an estimate for EBIT Margin over the Next Twelve Months.
Calculation:
EBIT NTM / Net Sales NTM using estimates consensus for EBIT and Net Sales

ROCE Historical
This is a weighted average of the Historical Returns On Capital Employed.
Calculation: (using up to 5 years of historical data when available)
[ROCE year N*5 + ROCE year (N-1)*4 + ROCE year (N-2)*3 + ROCE year (N-3)*2 + ROCE year (N-4)] / 15

ROE Last
ROE (Return on Equity) is one of the most widely used measures of how well a company is performing for its shareholders, as it indicates how much was earned for each unit invested by the owners. It is a relatively straightforward benchmark for investors to compare the company's use of its equity against other investments.
Calculation:
ROE=Net profit after preferred dividends (Last) / Average total equity for the last 2 years (in %)

Dividend Yield NTM
This is an estimate for Dividend Yield over the Next Twelve Months.
Calculation:
The median of dividend per share estimates divided by the last share price.